Form 990 for tax year 2024

Totals

Total revenue

$118,682,229

Total expenses

$116,892,326

Contributions and grants received

$97,641,210

Grants paid

$12,872,936

Program service revenue

$2,117,027

Investment income

$16,639,792

Other revenue

$2,284,200

Total assets, end of year

$225,713,097

Total liabilities, end of year

$40,204,543

Net assets or fund balances, end of year

$185,508,554

Program services expenses (Part IX)

$99,045,497

Management and general expenses

$5,380,932

Fundraising expenses

$12,465,897

Program service expenses (Part III)

$99,045,497

Program services were 84.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Mission and programs · 2024

• LUNG CANCER, ASTHMA, LUNG DISEASE AND TOBACCO CONTROL: AS PART OF OUR MISSION, THE AMERICAN LUNG ASSOCIATION IS COMMITTED TO SUPPORTING AND IMPROVING THE LIVES OF THE MORE THAN 35 MILLION PEOPLE LIVING WITH LUNG DISEASE - A LEADING CAUSE OF DEATH IN THE UNITED STATES. WE DO THIS BY INVESTING IN RESEARCH; ADVOCATING FOR POLICIES AND LEGISLATION THAT CHAMPION CLEAN AIR, OPTIMAL CARE AND REDUCED ACCESS TO TOBACCO PRODUCTS; AND PROVIDING PROGRAMS, RESOURCES AND SUPPORT TO HELP INDIVIDUALS LIVING WITH LUNG DISEASE AND THEIR FAMILIES TO BETTER UNDERSTAND AND MANAGE THEIR DISEASE.IN FISCAL YEAR 2025, THE AMERICAN LUNG ASSOCIATION RESEARCH INSTITUTE INVESTED $22 MILLION IN GROUNDBREAKING RESEARCH, REINFORCING OUR ROLE AS ONE OF THE NATION'S LARGEST PRIVATE FUNDERS OF LUNG HEALTH STUDIES. WE EXPANDED EDUCATIONAL PROGRAMS FOR PATIENTS, CAREGIVERS, AND HEALTHCARE PROVIDERS, AND DELIVERED TARGETED TOBACCO CESSATION INITIATIVES, INCLUDING EFFORTS TO PREVENT YOUTH TOBACCO USE AND SUPPORT CESSATION AMONG TEENS AND ADULTS. THROUGHOUT THE YEAR, WE ALSO CHAMPIONED CRITICAL HEALTHCARE AND CLEAN AIR PROTECTIONS - ADVOCATING FOR MEDICAID PRESERVATION, POLICIES AND PROGRAMS THAT LIMIT POLLUTION, AND FEDERAL FUNDING FOR LUNG DISEASE RESEARCH. IN MARCH, OUR LUNG FORCE HEROES TRAVELED TO WASHINGTON, DC, TO MEET WITH LAWMAKERS AND ADVOCATE FOR LIFESAVING COVERAGE AND SUPPORT FOR THOSE AFFECTED BY LUNG CANCER. IN NOVEMBER, WE RELEASED OUR 7TH ANNUAL "STATE OF LUNG CANCER" REPORT, HIGHLIGHTING A JUMP IN THE FIVE-YEAR LUNG CANCER SURVIVAL - TO 28.4%, AN INCREASE OF 52% OVER THE PAST DECADE. WHILE LUNG CANCER REMAINS THE DEADLIEST FORM OF CANCER, SIGNIFICANT ADVANCEMENTS IN TREATMENT AND CARE ARE HELPING PEOPLE TO LIVE LONGER AND HEALTHIER THAN EVER BEFORE. HINDERING PROGRESS, HOWEVER, ARE ONGOING GAPS IN THE RATES OF BIOMARKER TESTING - THE EVALUATION OF LUNG TUMOR TISSUE TO HELP DETERMINE AN INDIVIDUAL'S SPECIFIC TYPE OF LUNG CANCER, ALLOWING FOR PRECISE AND POTENTIALLY MORE SUCCESSFUL TREATMENT - AND LUNG CANCER SCREENING, AS HIGHLIGHTED IN THE REPORT. WE KNOW THAT IF LUNG CANCER IS CAUGHT BEFORE IT SPREADS, THE LIKELIHOOD OF SURVIVING FIVE YEARS OR MORE JUMPS TO 64%, AND THAT NEARLY ONE-QUARTER OF LUNG CANCER PATIENTS RECEIVE CHEMOTHERAPY OR RADIATION BEFORE UNDERGOING BIOMARKER TESTING. IN RESPONSE, WE CONTINUE TO EXPAND OUR PROGRAMS AND RESOURCES AIMED AT PROMOTING AWARENESS AND GREATER PARTICIPATION IN THESE LIFESAVING PROGRAMS. IN FISCAL YEAR 2025, WE LAUNCHED OUR BIOMARKER, EDUCATION, AWARENESS AND TESTING (BEAT) LUNG CANCER CAMPAIGN, AIMED AT PROMOTING THE IMPORTANCE AND VALUE OF BIOMARKER TESTING THROUGH NEW WEBSITE RESOURCES, TARGETED ADVERTISING, AND EDUCATIONAL VIDEOS. WE ALSO WORKED WITH THE AD COUNCIL TO CREATE A NEW PUBLIC SERVICE ANNOUNCEMENT (PSA), "IF YOUR LUNGS COULD TALK," HIGHLIGHTING THE IMPORTANCE OF LUNG CANCER SCREENING, ESPECIALLY AMONG INDIVIDUALS WITH A HISTORY OF TOBACCO USE. THE CAMPAIGN RESULTED IN 649,000 VISITS TO OUR WEBSITE AND 250,000 COMPLETIONS OF OUR SAVED BY THE SCAN QUIZ TO DETERMINE SCREENING ELIGIBILITY. OF THE MORE THAN 1.5 MILLION PEOPLE WHO HAVE TAKEN OUR ONLINE QUIZ, 20% LEARNED THEY QUALIFY FOR LOW- OR NO-COST SCREENING. BECAUSE CLINICAL TRIALS CAN PLAY A CRITICAL, LIFESAVING ROLE IN ENSURING OPTIMAL LUNG CANCER TREATMENT AND CARE, WE LAUNCHED AN AWARENESS, TRUST AND ACTION PROGRAM TO SPECIFICALLY PROMOTE THE IMPORTANCE AND AVAILABILITY OF CLINICAL TRIALS AMONG HISPANIC LUNG CANCER PATIENTS AND CAREGIVERS. HISPANIC INDIVIDUALS REPRESENT 19% OF THE POPULATION BUT JUST 6% OF CLINICAL TRIAL PARTICIPANTS. THE PROGRAM AIMS TO RAISE AWARENESS ABOUT CLINICAL TRIALS, ADDRESS MISCONCEPTIONS, AND EMPOWER PATIENTS AND CAREGIVERS TO ULTIMATELY IMPROVE LUNG CANCER CARE AND OUTCOMES. OUR NEW AND IMPROVED EDUCATIONAL PROGRAMS THIS YEAR INCLUDED RESOURCES AND TOOLS FOR INDIVIDUALS LIVING WITH COPD, ASTHMA, BRONCHIECTASIS, AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS, PULMONARY ARTERIAL HYPERTENSION AND PNEUMOCOCCAL PNEUMONIA. TO SUPPORT SCHOOL HEALTH PROFESSIONALS, WE INTRODUCED A NEW GUIDE DESIGNED TO HELP THEM SECURE AND MAINTAIN FUNDING FOR EMERGENCY STOCK ASTHMA MEDICATION. WE ALSO LAUNCHED THE LUNG-FRIENDLY ENVIRONMENTS FOR YOUTH INITIATIVE-AN ONLINE HUB PROVIDING COMPREHENSIVE STRATEGIES AND RESOURCES FOR ADDRESSING ASTHMA, TOBACCO, CLEAN AIR AND MORE IN SCHOOLS AND COMMUNITY ORGANIZATIONS. IN ADDITION, WE CONTINUED TO SUPPORT AND GROW OUR PATIENT AND CAREGIVER SUPPORT PROGRAMS. MEMBERSHIP IN OUR PATIENT & CAREGIVER NETWORK - A NATIONWIDE, ONLINE SUPPORT PROGRAM PROVIDING EDUCATION, TOOLS AND WELLNESS AND OTHER RESOURCES FOR INDIVIDUALS LIVING WITH LUNG DISEASE AND THEIR CAREGIVERS - GREW TO 18,048 MEMBERS IN FISCAL YEAR 2025, REPRESENTING ALL STATES AND PUERTO RICO, A 39% INCREASE. AND OUR 11 ONLINE SUPPORT COMMUNITIES NOW SERVE 253,697 MEMBERS NATIONWIDE, OFFERING A SAFE, WELCOMING SPACE FOR THOSE FACING LUNG CANCER, CHRONIC LUNG CONDITIONS OR TOBACCO CESSATION CHALLENGES.AS FALL APPROACHED, WE ENCOURAGED IMMUNIZATION AS A SAFE AND EFFECTIVE WAY TO REDUCE THE RISK OF SEVERE SYMPTOMS AND HOSPITALIZATIONS CAUSED BY RESPIRATORY VIRUSES - ESPECIALLY FOR THOSE MOST VULNERABLE, INCLUDING ADULTS 65 AND OLDER AND INDIVIDUALS WITH LUNG CONDITIONS OR OTHER CHRONIC ILLNESSES.OUR EFFORTS IN FISCAL YEAR 2025 INCLUDED NEW AND ONGOING CAMPAIGNS PROMOTING THE IMPORTANCE OF VACCINES FOR THE PREVENTION OF INFLUENZA, OR THE FLU, RESPIRATORY SYNCYTIAL VIRUS, OR RSV - IN ADULTS, BABIES AND YOUNG CHILDREN - AND COVID-19. OUR COMPREHENSIVE RSV IN BABIES CAMPAIGN - AIMED AT PARENTS AND SOON-TO-BE PARENTS ON HOW TO PROTECT INFANTS AND TODDLERS FROM RSV, THE LEADING CAUSE OF INFANT HOSPITALIZATION - REACHED MILLIONS OF PEOPLE.DURING FLU SEASON, WE ALSO IMPLEMENTED TARGETED OUTREACH EFFORTS IN RURAL COMMUNITIES WITH LOW INFLUENZA VACCINATION RATES - ARKANSAS, MISSISSIPPI, WEST VIRGINIA, MONTANA AND KENTUCKY - AND AMONG VULNERABLE POPULATIONS, INCLUDING HOMELESS AND LOW-INCOME INDIVIDUALS WITH TUBERCULOSIS IN GEORGIA.TOBACCO USE REMAINS THE LEADING CAUSE OF PREVENTABLE DEATH IN THIS COUNTRY. AND WHILE YOUTH TOBACCO USE HAS DECLINED TO THE LOWEST LEVEL IN 25 YEARS (WITH HELP FROM THE AMERICAN LUNG ASSOCIATION'S RELENTLESS ADVOCACY AND AWARENESS EFFORTS), THE NUMBER OF MIDDLE AND HIGH SCHOOL STUDENTS WHO USE TOBACCO PRODUCTS - 2.25 MILLION - IS STILL TOO HIGH, AS TOBACCO COMPANIES USE AGGRESSIVE MARKETING TACTICS TO APPEAL TO AND ADDICT A NEW GENERATION. OUR 23RD "STATE OF TOBACCO CONTROL" REPORT HIGHLIGHTED THE IMPORTANCE OF ONGOING FUNDING FOR TOBACCO PREVENTION AND YOUTH SMOKING PROGRAMS TO REDUCE DEATH AND DISEASE. IN THE SPRING OF 2025, WE FOLLOWED UP WITH A SECOND REPORT EXAMINING THE IMPACT OF DRAMATIC CUTS TO FEDERAL TOBACCO PROGRAMS.WHILE WE STRONGLY ADVOCATED FOR THE PRESERVATION OF THESE PROGRAMS, WE CONTINUED TO SUPPORT STATE AND LOCAL TOBACCO PREVENTION EFFORTS, HELPING INDIVIDUALS WHO WANT TO STOP SMOKING THROUGH OUR FREEDOM FROM SMOKING CLASSES AND LUNG HELPLINE AND DEVELOPING NEW PROGRAMS TO PREVENT AND REDUCE TOBACCO USE. IN FISCAL YEAR 2025, WE REMAINED COMMITTED TO EDUCATING TEACHERS, SCHOOL ADMINISTRATORS, CHILDREN, TEENS AND PARENTS ABOUT THE DANGERS OF VAPING AND TOBACCO. WITH THE AD COUNCIL, WE LAUNCHED A NEW YOUTH VAPING PREVENTION PUBLIC SERVICE CAMPAIGN, "YOU'RE THE BEST PERSON," PROVIDING A HUMOROUS LOOK AT WHY PARENTS ARE THE BEST PEOPLE TO TALK TO THEIR KIDS ABOUT THE DANGERS OF VAPING. THE CAMPAIGN DROVE MORE THAN 330,000 PEOPLE TO OUR WEBSITE RESOURCES ON YOUTH VAPING. WE ALSO LAUNCHED A NEW YOUTH TOBACCO TREATMENT PLAN, A WORKSHEET AND REFERENCE TO HELP TEENS AND YOUNG ADULTS BETTER UNDERSTAND TOBACCO-USE TRIGGERS, COPING STRATEGIES, THE BENEFITS OF QUITTING AND HOW TO GET HELP. MOST IMPORTANTLY, OUR TOBACCO PREVENTION EFFORTS ARE MAKING A DIFFERENCE: ADULT CIGARETTE USE DROPPED FROM 14.0% IN 2019 TO 9.9% IN 2024, AND E-CIGARETTE USE AMONG MIDDLE AND HIGH SCHOOL STUDENTS DECLINED FROM 20.0% IN 2019 TO 5.9% IN 2024, A 71% REDUCTION.

  Expenses $54,897,785 · Revenue $2,578,572

• RESEARCH: FOR MORE THAN A CENTURY, THE AMERICAN LUNG ASSOCIATION HAS DRIVEN LUNG HEALTH ADVANCEMENTS AND INNOVATION BY SUPPORTING MEDICAL RESEARCH THAT IS HELPING PEOPLE WITH LUNG DISEASE LIVE LONGER, HEALTHIER LIVES. IN FISCAL YEAR 2025, THE AMERICAN LUNG ASSOCIATION RESEARCH INSTITUTE CONTINUED TO FUND HIGH-IMPACT, LIFESAVING RESEARCH, BRINGING TOGETHER THE BEST SCIENTIFIC MINDS TO ADDRESS CRITICAL LUNG HEALTH CHALLENGES. OUR GROWING RESEARCH INVESTMENT - $225 MILLION SINCE 2000 - HAS MADE US ONE OF THE LARGEST PRIVATE FUNDERS OF LUNG HEALTH RESEARCH IN THE UNITED STATES. IN SEPTEMBER, OUR RESEARCH AWARDS INCLUDED 139 GRANTS TO PROMISING AND ESTABLISHED SCIENTISTS WORKING ON SOLUTIONS AND TREATMENTS FOR A BROAD RANGE OF LUNG HEALTH CHALLENGES, INCLUDING THE LINK BETWEEN OBESITY AND SEVERE RESPIRATORY DISEASE, THE ROLE OF INFLAMMATION IN PULMONARY FIBROSIS, AND NEW TARGETED LUNG CANCER TREATMENTS. EACH YEAR, OUR RESEARCH INVESTMENT ALSO SUPPORTS OUR AIRWAYS CLINICAL RESEARCH CENTERS NETWORK, THE LARGEST NONPROFIT CLINICAL RESEARCH NETWORK PROVIDING ASTHMA AND COPD CLINICAL TRIALS AT PROMINENT ACADEMIC MEDICAL CENTERS, AS WELL AS INNOVATIVE INDUSTRY AND NONPROFIT PARTNERSHIPS TO ACCELERATE DISCOVERY. THIS YEAR, WE PROVIDED A $200,000 AMERICAN LUNG ASSOCIATION RESEARCH INSTITUTE GRANT TO TEXAS BIOMEDICAL RESEARCH INSTITUTE TO STUDY A UNIVERSAL, ONE-TIME VACCINE. WE ALSO REACHED A CRITICAL MILESTONE IN OUR LUNG HEALTH COHORT RESEARCH STUDY - RECRUITING NEARLY 3,000 PARTICIPANTS FOR OUR PIONEERING PROJECT WHERE WE EXPECT TO FOLLOW HEALTHY ADULTS FOR APPROXIMATELY FIVE YEARS, WITH THE GOAL OF IDENTIFYING RISK FACTORS FOR LUNG DISEASE. IN FISCAL YEAR 2025, WE ALSO CONTINUED TO SUPPORT AND FUND ORGANIZATIONS COMMITTED TO ADVANCING RESEARCH. IN FISCAL YEAR 2025, THIS INCLUDED SPONSORING COPD INET IN BOSTON - HELD FOR THE FIRST TIME IN THE UNITED STATES - BRINGING TOGETHER 100 SCIENTISTS COMMITTED TO ADVANCING COPD RESEARCH FROM THE LABORATORY TO PATIENT TREATMENT AND CARE.

  Expenses $21,514,470 · Grants $12,872,936 · Revenue $1,011,090

• ADVOCACY AND ENVIRONMENTAL:EACH YEAR, THE AMERICAN LUNG ASSOCIATION SUPPORTS POLICIES AND LEGISLATION THAT HELP EVERYONE BREATHE EASIER. THIS INCLUDES ADVOCATING FOR LAWS THAT PROTECT OUR CHILDREN FROM DEADLY AIR POLLUTION AND TOBACCO PRODUCTS, AND PROVIDING FUNDING FOR CRITICAL LUNG DISEASE RESEARCH, HEALTHCARE COVERAGE, AND TOBACCO CESSATION, ASTHMA AND OTHER VITAL HEALTH PROGRAMS.IN FISCAL YEAR 2025, WE FOUGHT VIGOROUSLY TO PRESERVE LIFESAVING FEDERAL FUNDING FOR MEDICAID, ALONG WITH TAX CREDITS AND OTHER PROGRAMS PROVIDING COVERAGE FOR MORE THAN 11 MILLION INDIVIDUALS - ALL THREATENED UNDER A PROPOSED BILL, WHICH IS NOW LAW. WE ALSO ADVOCATED AGAINST PROPOSED CUTS IN PROGRAM STAFF AND SPENDING THAT SUPPORT LUNG HEALTH.OUR ADVOCACY EFFORTS HELPED TO PRESERVE HEALTHCARE COVERAGE FOR PREVENTATIVE CARE, INCLUDING LUNG CANCER SCREENING; THE REINTRODUCTION OF THE SOAR ACT TO PROVIDE EQUITABLE ACCESS TO PORTABLE OXYGEN, ALLOWING PEOPLE TO LIVE MORE ACTIVE LIVES; AND A SUPREME COURT RULING IN FAVOR OF THE FOOD AND DRUG ADMINISTRATION PROHIBITING TOBACCO COMPANIES FROM EMPLOYING SPECIFIC MARKETING STRATEGIES TO PROMOTE CERTAIN E-CIGARETTE PRODUCTS. IN FISCAL YEAR 2025, WE HOSTED TWO ADVOCACY EVENTS. IN ADDITION TO OUR ANNUAL LUNG FORCE ADVOCACY DAY IN THE SPRING, WE HELD OUR SECOND RESPIRATORY ADVOCACY DAY IN SEPTEMBER. THIS EVENT UNITED DOZENS OF INDIVIDUALS LIVING WITH ASTHMA, COPD, PULMONARY FIBROSIS, PULMONARY ARTERIAL HYPERTENSION, AND OTHER LUNG DISEASES. THEY SHARED THEIR STORIES AND MET WITH CONGRESSIONAL REPRESENTATIVES TO ADVOCATE FOR THE PROTECTION OF HEALTHCARE COVERAGE AND INCREASED FUNDING FOR RESEARCH AND VITAL PROGRAMS THAT SUPPORT THOSE AFFECTED BY RESPIRATORY CONDITIONS. THROUGHOUT THE YEAR, WE ALSO ADVOCATED FOR POLICIES AND PROGRAMS - AND THE PROTECTION OF STAFF AND FUNDING AT THE ENVIRONMENTAL PROTECTION AGENCY - TO IMPROVE THE AIR WE BREATHE. THIS INCLUDED SUPPORTING LEGISLATION TO LIMIT MERCURY AND OTHER POISONOUS EMISSIONS FROM POWER PLANTS AND OTHER POLLUTION SOURCES AND PROTECTING ENERGY EFFICIENCY PROGRAMS AND CLEAN CAR AND TRUCK WAVERS. ACCORDING TO OUR 26TH ANNUAL "STATE OF THE AIR" (SOTA) REPORT, NEARLY HALF OF PEOPLE LIVING IN THE UNITED STATES ARE EXPOSED TO DANGEROUS AIR POLLUTION LEVELS, WITH 156 MILLION PEOPLE (25 MILLION MORE THAN THE PREVIOUS YEAR) LIVING IN AREAS THAT RECEIVED AN "F" GRADE FOR OZONE OR PARTICLE POLLUTION. IN ADDITION, WE PUBLISHED TWO SUPPLEMENTAL REPORTS PROVIDING CRITICAL INSIGHTS ON HOW SATELLITE TECHNOLOGY AND OTHER INNOVATIVE SOLUTIONS CAN IMPROVE THE DETECTION OF PARTICLE POLLUTION AND NITROGEN DIOXIDE HOT SPOTS - KEY STEPS TO IMPROVING AIR QUALITY. TO SUPPORT INDIVIDUALS LIVING WITH LUNG DISEASES IN COMMUNITIES DISPROPORTIONATELY IMPACTED BY PARTICLE AND OZONE POLLUTION, WE DEVELOPED A NEW PROGRAM IN PARTNERSHIP WITH THE CVS FOUNDATION. THROUGH THIS PROJECT, WE DISTRIBUTED 346 AIR QUALITY SENSORS TO HEALTHCARE ORGANIZATIONS AND PEOPLE IN PHOENIX. DEVASTATING WILDFIRES CONTINUED TO THREATEN AIR QUALITY THROUGHOUT THE YEAR. IN JANUARY, HIGH WINDS AND DRY CONDITIONS FUELED THE SPREAD OF DEVASTATING WILDFIRES THROUGHOUT LOS ANGELES COUNTY, DESTROYING MORE THAN 12,000 HOMES, BUSINESSES, SCHOOLS AND OTHER STRUCTURES. FORTUNATELY, WE WERE ABLE TO SWIFTLY DISSEMINATE ESSENTIAL INFORMATION AND RESOURCES - THROUGH OUR WEBSITE, SOCIAL MEDIA AND MEDIA INTERVIEWS WITH OUR EXPERTS - TO HELP SAFEGUARD INDIVIDUALS AND FAMILIES, PARTICULARLY THOSE LIVING WITH ASTHMA AND OTHER CHRONIC LUNG CONDITIONS, FROM SMOKE AND OTHER SOURCES OF AIR POLLUTION. THROUGH OUR STRATEGIC PARTNERSHIPS WITH INDUSTRY LEADERS AND VOLUNTEERS WE WERE ABLE TO SECURE AND DISTRIBUTE INDUSTRIAL-GRADE AND IN-HOME AIR PURIFIERS, N-95 MASKS AND OTHER SUPPLIES TO INDIVIDUALS LIVING WITH LUNG DISEASE, SCHOOLS AND COMMUNITY ORGANIZATIONS. WE ALSO FORGED MEANINGFUL, SUSTAINABLE PARTNERSHIPS THAT PROMOTE ONGOING REBUILDING AND RESILIENCE IN THE WILDFIRE-IMPACTED COMMUNITIES THROUGHOUT SOUTHERN CALIFORNIA. AS WILDFIRES ARE AN ONGOING CHALLENGE THROUGHOUT NORTH AMERICA, WE RENEWED OUR PARTNERSHIP WITH THE CANADIAN LUNG ASSOCIATION TO HELP RAISE AWARENESS ABOUT THE HEALTH RISKS ASSOCIATED WITH WILDFIRE SMOKE. WE ALSO DEEPENED OUR COMMITMENT TO INDOOR AIR IN FISCAL YEAR 2025, BY SECURING ENVIRONMENTAL PROTECTION AGENCY (EPA) FUNDING TO LAUNCH THE CLEAN AIR SCHOOL CHALLENGE, A MULTI-YEAR CAMPAIGN EMPOWERING K-12 SCHOOLS TO IMPROVE THE QUALITY OF THEIR AIR. WE ALSO AWARDED OUR INAUGURAL INDOOR AIR RESEARCH AWARD TO A GROUNDBREAKING RESEARCHER STUDYING THE HEALTH EFFECTS OF INDOOR AIR ON MATERNAL AND CHILD HEALTH.

  Expenses $22,633,242 · Revenue $1,063,668

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

• JOHNS HOPKINS UNIVERSITY

  $825,000

  RESEARCH

• NORTHWESTERN UNIVERSITY

  $790,907

  RESEARCH

• TRUSTEES OF BOSTON UNIVERSITY

  $600,000

  RESEARCH

• ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

  $500,000

  RESEARCH

• NEMOURS CHILDREN CLINIC

  $474,465

  RESEARCH

• UNIVERSITY OF KANSAS CENTER FOR RESEARCH

  $467,495

  RESEARCH

• DUKE UNIVERSITY

  $461,793

  RESEARCH

• MEMORIAL SLOAN KETTERING CANCER CENTER

  $400,000

  RESEARCH

• TEXAS BIOMEDICAL RESEARCH INSTITUTE

  $400,000

  RESEARCH

• THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES

  $400,000

  RESEARCH

The 10 largest by cash amount. The API serves every itemized grant.

Provenance

Return type

form_990

Tax year

2024

Filed

6 March 2026

IRS schema version

2024v5.5

Source object

202640659349301724

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.